Latest News

Friday, June 24, 2016 | Medical Studies

Industry Incentives May Drive Pricier Anti-VEGF Drug Use

Ophthalmologists who receive incentives from industry are more likely to administer costlier drugs, according to a new report that adds another piece to the puzzle of physician -- industry interaction…

Read the full story

Friday, June 24, 2016 | Retina, Novartis

CHMP Positive Opinion for Once-Daily Nevanac 3mg/ml (Nepafenac) Eye Drops in Europe

On June 24, 2016, the Committee for Medicinal Products for Human Use (CHMP) recommended the approval of once-daily Nevanac 3mg/ml (nepafenac) eye drops, suspension in Europe for the reduction in risk …

Read the full story

Friday, June 24, 2016 | Acquisitions/Mergers, Essilor

Essilor Acquires AllAboutVision.com

Essilor of America has acquired AllAboutVision.com, VMail has learned. AllAboutVision.com is a consumer website designed as a source of unbiased and comprehensive information about eye health, vision …

Read the full story

Thursday, June 23, 2016 | Medical Studies

Temporary Blindness Tied to Smartphone Use in Dark

Warning: Looking at your smartphone while lying in bed at night could wreak havoc on your vision. Two women went temporarily blind from constantly checking their phones in the dark, say doctors who ar…

Read the full story

Thursday, June 23, 2016 | Miscellaneous

Technavio Announces Top 19 Vendors in the Global Vision Care Market from 2016 to 2020

Technavio has announced the top 19 leading vendors in their recent global vision care market 2016-2020 report. Vendors are identified based on their revenue and market dominance in terms of experience…

Read the full story

Thursday, June 23, 2016 | Health Care

Your Doctor Will See You in This Telemedicine Kiosk

On the day abdominal pain and nausea struck Jessica Christianson at the office, she discovered how far telemedicine has come. Rushing to a large kiosk in the lobby of the Palm Beach County School Dist…

Read the full story

Thursday, June 23, 2016 | Clinical Trials, Partnerships

Biocon, Quark Announce Initiation of Pivotal Phase 2/3 Study of QPI-1007 in Rare Eye Disease in India

Biocon and Quark Pharmaceuticals announced the randomization of the first patient in India in the pivotal global phase 2/3 study of QPI-1007, a novel siRNA (small interfering RNA) drug candidate for o…

Read the full story

Wednesday, June 22, 2016 | Awards, Prevent Blindness

Prevent Blindness Announces Recipient of Joanne Angle Investigator Award

Prevent Blindness announced the recipient of its 2016 Joanne Angle Investigator Award is Rajeev S. Ramchandran, MD, MBA, Associate Professor of Ophthalmology, University of Rochester School of Medicin…

Read the full story

Wednesday, June 22, 2016 | Practice Development

The Eye Care Leaders Group Introduces Practice Consulting Services

The Eye Care Leaders Group (ECL Group) announced the launch of its practice consulting services to help eye care physicians optimize their operations and grow their practices, according to a company n…

Read the full story

Wednesday, June 22, 2016 | Medical Studies

Could Restoring Electrical Signals Help Heal Diabetic Wounds?

For the first time, researchers show that slow healing in diabetic wounds is linked to impaired, naturally occurring electrical signals in the tissue. They suggest the finding could open up new ways t…

Read the full story

Wednesday, June 22, 2016 | Acquisitions/Mergers, Allergan

Teva, Allergan to Divest Generic Products to Impax for Roughly $586 million

Impax Laboratories said it signed definitive agreements totalling about $586 million with Teva and Allergan to purchase "a broad portfolio" of generic products, including 15 curren…

Read the full story

Tuesday, June 21, 2016 | Medical Studies, American Academy of Ophthalmology

Nearly 10 Million Adults Found to Be Severely Nearsighted in the United States

A new study estimates that 9.6 million adults in the United States are highly myopic. Of those, nearly 820,000 have a degenerative form of the disease and more than 41,000 suffer from myopic choroidal…

Read the full story

Tuesday, June 21, 2016 | Blindness, Partnerships, Envision

Envision Partners with e2e Fund and LC Industries to Create High Tech Employment for the Blind and Visually Impaired

Envision announced the collaboration with the Wichita-based entrepreneurial group e2e to bring more tech jobs to Wichita, Kansas, specifically for the blind and visually impaired. The groups have enli…

Read the full story

Tuesday, June 21, 2016 | Product Releases, Volk Optical

Volk iNview Portable Ophthalmic Imager Now iPhone SE Compatible

Volk Optical has upgraded its Volk iNview portable fundus camera, expanding the range of device compatibility to include the iPhone SE, while improving both the app and internal optics for even better…

Read the full story

Tuesday, June 21, 2016 | Clinical Trials, Nicox

FDA Grants Priority Review for Nicox's AC-170 New Drug Application

Nicox announced that the FDA has accepted the company's new drug application for AC-170, a novel, proprietary, cetirizine eye drop formulation for the treatment of ocular itching associated with a…

Read the full story
Load More
 Stock Price  Change 
 Aerie Pharmaceuticals, Inc. $17.14  0.00% 
 Akorn, Inc. $27.77  0.00% 
 Alimera Sciences, Inc. $1.40  0.00% 
 Allergan $225.72  0.00% 
 Avalanche Biotechnologies $4.14  0.00% 
 Bayer $97.60  0.00% 
 Can-Fite Biopharma $2.60  0.00% 
 Carl Zeiss Meditec $34.20  0.00% 
 Clearside Biomedical $6.80  0.00% 
 Cooper Companies, Inc. $166.80  0.00% 
 Eleven Biotherapeutics $2.14  0.00% 
 Escalon Medical Corp. $0.76  0.00% 
 Essilor International $115.00  0.00% 
 Glaukos $28.17  0.00% 
 Imprimis Pharmaceuticals, Inc. $3.98  0.00% 
 Inotek Pharmaceuticals $7.25  0.00% 
 IRIDEX Corporation $14.50  0.00% 
 Johnson & Johnson $115.63  0.00% 
 Luxottica Group, S.p.A. $49.57  0.00% 
 Merck & Company, Inc. $55.88  0.00% 
 NicOx $10.46  0.10% 
 NovaBay Pharmaceuticals, Inc. $2.52  0.00% 
 Novartis AG Common Stock $77.10  0.00% 
 Ocular Therapeutix $5.17  0.00% 
 Ophthotech Corporation $51.99  0.00% 
 QLT $1.35  0.00% 
 Quantel $3.27  0.00% 
 Regeneron $339.48  0.00% 
 Roche $30.77  0.00% 
 Second Sight Medical Products $3.56  0.00% 
 Shire $166.03  0.00% 
 STAAR Surgical Company $5.54  0.00% 
 TearLab Corporation $0.66  0.00% 
 Thrombogenics $2.92  0.00% 
 Valeant Pharmaceuticals $20.27  0.00% 
 Xoma $0.52  0.00%